Omic Studies of Neurodegenerative Disease - Part A

Erscheinungsjahr 2015
ISBN: 978-0-12-801480-6
Verlag: William Andrew Publishing

Buch, Englisch, 214 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 430 g

Omic Studies of Neurodegenerative Disease: Part A is part of a well-established international series on neuroscience that examines major areas of basic and clinical research, along with emerging and promising subfields.

The book informs the reader on the current state of the studies used to evaluate the mechanisms, causes, and treatment of neurodegeneration through a combination of literature reviews and examples of current research.

Zielgruppe

<p>The volume will appeal to a wide audience including students and researchers from across the life science community, particularly those interested in neuroscience.</p>

Autoren/Hrsg.

Weitere Mitwirkende

Hurley, Michael J.

Fachgebiete

• Interdisziplinäres Wissenschaften Wissenschaften Interdisziplinär Neurowissenschaften, Kognitionswissenschaft
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft
• Naturwissenschaften Biowissenschaften Entwicklungsbiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften Neurobiologie, Verhaltensbiologie

Inhaltsverzeichnis

1. Alzheimer's Disease: Genomics and Beyond Fuhai Song, Guangchun Han, Zhouxian Bai, Xing Peng, Jiajia Wang and Hongxing Lei 2. The Potential of Proteomics in Understanding Neurodegeneration Ramavati Pal, Jan Petter Larsen and Simon Geir Moller 3. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases Annapurna Nayak, Gregory Salt, Sunil K. Verma and Uday Kishore 4. Uncovering Neurodegenerative Protein Modifications Via Proteomic Profiling Xavier Gallart-Palau, Aida Serra and Siu Kwan Sze 5. Comparative Proteomics for the Evaluation of Proteins Expression and Modifications in Neurodegenerative Diseases Antonio Conti and Massimo Alessio

Über Autor(innen)

Hurley, Michael J.
Michael Hurley has 20 years of experience conducting research in to the cause and consequence of neurodegeneration in brain. He currently works at Imperial College London.